Related Experiment Videos
In vivo detection of metabolic changes in a mouse model of scrapie using nuclear magnetic resonance spectroscopy
J D Bell1, I J Cox, S C Williams
1NMR Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London, U.K.
Abstract:
In vivo proton nuclear magnetic resonance (NMR) spectroscopy studies of scrapie in a mouse model have shown the appearance of an abnormal peak in the brain early in the incubation period. This abnormal peak was detected weeks before the detection of a protease-resistant form of a membrane protein and vacuolar histopathology in vitro, and several months before clinical signs, and the signal increased in intensity as the disease progressed. In the chronic stage of the disease, a reduction in N-acetyl aspartate levels was observed using in vivo and in vitro proton NMR spectroscopy.
Insights
Early detection of scrapie disease in mice is possible using proton nuclear magnetic resonance (NMR) spectroscopy. This technique identified abnormal brain signals before other disease markers, aiding in early diagnosis.
Area of Science:
- Neuroscience
- Biochemistry
- Medical Imaging
Background:
- Scrapie is a fatal neurodegenerative disease.
- Early detection of scrapie is crucial for understanding disease progression.
- Current diagnostic methods detect scrapie late in the disease course.
Purpose of the Study:
- To investigate the potential of in vivo proton nuclear magnetic resonance (NMR) spectroscopy for early detection of scrapie in a mouse model.
- To correlate NMR findings with other established markers of scrapie.
- To monitor disease progression using NMR spectroscopy.
Main Methods:
- In vivo and in vitro proton nuclear magnetic resonance (NMR) spectroscopy was performed on mice during scrapie infection.
- Brain samples were analyzed for abnormal peaks and changes in metabolite levels.
- Detection of protease-resistant prion protein and vacuolar histopathology were used as comparative markers.
Main Results:
- An abnormal peak in the brain was detected by proton NMR spectroscopy early in the scrapie incubation period.
- This abnormal signal appeared weeks before protease-resistant prion protein and vacuolar histopathology.
- The abnormal signal intensity increased as the disease progressed, and N-acetyl aspartate levels decreased in the chronic stage.
Conclusions:
- In vivo proton NMR spectroscopy can detect scrapie in mice significantly earlier than conventional methods.
- NMR-detectable brain changes precede pathological hallmarks of scrapie.
- Proton NMR spectroscopy is a promising tool for early diagnosis and monitoring of scrapie progression.